Home \ Select Medical Holdings Corp. (SEM)

Select Medical Holdings Corp. (SEM)

Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM). Investors who purchased Select Medical prior to March 2, 2026, and continue to hold to the present are encouraged to obtain additional information and assist the investigation.

Select Medical Investigation Details

The investigation concerns whether Select Medical’s board of directors breached its fiduciary duties and failed to provide relevant information to its shareholders before the merger. On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a price of $16.50 per share in cash. Following the closing of the proposed transaction, the company’s shares will no longer be publicly traded. The investigation focuses on whether Select Medical investors are being fairly compensated for their shares and whether the company’s leadership breached their fiduciary duties by approving the $16.50 per share transaction.

What’s Next for Select Medical Investors?

If you are aware of any facts relating to this investigation or purchased Select Medical securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911

No Cost to Select Medical Investors

We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC For Select Medical Securities Investigation?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace,” said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.

Select Medical Holdings Corp.